Free shipping on all orders over $ 500

Niraparib (MK-4827) tosylate

Cat. No. M8926

All AbMole products are for research use only, cannot be used for human consumption.

Niraparib (MK-4827) tosylate Structure
Synonym:

MK-4827 tosylate

Size Price Availability Quantity
10mg USD 110  USD110 In stock
25mg USD 220  USD220 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Niraparib tosylate inhibits PARP1/PARP2 with IC50 of 3.8 nM/2.1 nM respectively. MK-4827 (Niraparib) inhibits PARP activity with EC50=4 nM and EC90=45 nM in a whole cell assay. MK-4827 inhibits proliferation of cancer cells with mutant BRCA-1 and BRCA-2 with CC50 in the 10−100 nM range.

MK-4827 is well tolerated in vivo and demonstrates efficacy as a single agent in a xenograft model of BRCA-1 deficient cancer. MK-4827 enhances radiation response of p53 mutant Calu-6 tumor in both cases, with the single daily dose of 50 mg/kg being more effective than 25 mg/kg given twice daily.

Protocol (for reference only)
Cell Experiment
Cell lines V-C8 cells
Preparation method V-C8 (BRCA2-negative) Chinese hamster cells are treated with the PARP inhibitor MK-4827 for 24 h, washed and incubated in drug-free medium for 5-7 days until colonies formed.
Concentrations 50 nM
Incubation time 24 h
Animal Experiment
Animal models Female nude mice (Ncr Nu/Nu)
Formulation Suspended in 0.5% Methocel in deionized water
Dosages 25 or 50 mg/kg
Administration p.o.
Chemical Information
Molecular Weight 492.59
Formula C19H20N4O.C7H8O3S
CAS Number 1038915-73-9
Solubility (25°C) DMSO: ≥ 60 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Bridges KA, et al. Oncotarget. Niraparib (MK-4827), a novel poly(ADP-Ribose) polymerase inhibitor, radiosensitizes human lung and breast cancer cells.

[2] Mueller S, et al. Anticancer Res. Poly (ADP-Ribose) polymerase inhibitor MK-4827 together with radiation as a novel therapy for metastatic neuroblastoma.

[3] Patel AG, et al. J Biol Chem. Enhanced killing of cancer cells by poly(ADP-ribose) polymerase inhibitors and topoisomerase I inhibitors reflects poisoning of both enzymes.

[4] Wang L, et al. Invest New Drugs. MK-4827, a PARP-1/-2 inhibitor, strongly enhances response of human lung and breast cancer xenografts to radiation.

Related PARP Products
2-Methylquinazolin-4-ol

2-Methylquinazolin-4-ol is a potent competitive poly(ADP-ribose) synthetase inhibitor, with a Ki of 1.1 μM. 2-Methylquinazolin-4-ol mammalian aspartate transcarbamylase (ATCase) inhibitor, with IC50 of 0.20 mM.

DPQ 

DPQ is a potent PARP-1 inhibitor.

OUL232 

OUL232 is a potent inhibitor of mono-ARTs PARP7, PARP10, PARP11, PARP12, PARP14, and PARP15.

AZ3391 

AZ3391 is a potent inhibitor of PARP.

PARP1-IN-5 

PARP1-IN-5 is a low toxicity, orally active, potent and selective PARP-1 inhibitor (IC50 =14.7 nM).

  Catalog
Abmole Inhibitor Catalog




Keywords: Niraparib (MK-4827) tosylate, MK-4827 tosylate supplier, PARP, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.